Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
3.
Intern Med ; 60(22): 3559-3567, 2021 Nov 15.
Article in English | MEDLINE | ID: mdl-34511566

ABSTRACT

Objective Various neurological manifestations have been increasingly reported in coronavirus disease 2019 (COVID-19). We determined the neurological features and long-term sequelae in hospitalized COVID-19 patients. Methods We retrospectively studied 95 consecutive hospitalized patients with COVID-19 between March 1 and May 13, 2020. Acute neurological presentations (within two weeks of the symptom onset of COVID-19) were compared between 60 non-severe and 35 severely infected patients who required high-flow oxygen. In the 12 ventilated patients (the most severe group), we evaluated neurological complications during admission, subacute neurological presentations, and neurological sequelae (51 and 137 days from the onset [median], respectively). Results Of the 95 patients (mean age 53 years old; 40% women), 63% had acute neurological presentations, with an increased prevalence in cases of severe infections (83% vs. 52%, p<0.001). Impaired consciousness and limb weakness were more frequent in severe patients than in non-severe ones (0% vs. 49%; p<0.001, and 0% vs. 54%; p<0.001, respectively). In the most severe group (mean age 72 years old; 42% women), 83% of patients had neurological complications [cerebrovascular disease (17%), encephalopathy (82%), and neuropathy (55%)], and 92% had subacute neurological presentations [impaired consciousness (17%), higher brain dysfunction (82%), limb weakness (75%), and tremor (58%)]. Neurological sequelae were found in 83% of cases, including higher brain dysfunction (73%), limb weakness (50%), and tremor (58%). Conclusions Neurological manifestations are common in COVID-19, with the possibility of long-lasting sequelae.


Subject(s)
COVID-19 , Nervous System Diseases , Aged , Female , Hospitalization , Humans , Male , Middle Aged , Nervous System Diseases/epidemiology , Nervous System Diseases/etiology , Retrospective Studies , SARS-CoV-2
4.
Am J Case Rep ; 22: e932958, 2021 Aug 22.
Article in English | MEDLINE | ID: mdl-34420027

ABSTRACT

BACKGROUND Creutzfeldt-Jakob disease (CJD) is an irreversible, neurodegenerative, prion disease presenting with cognitive, behavioral, and motor dysfunction. The clinical presentations or laboratory findings of treatable autoimmune and metabolic processes may mimic those of CJD. Hepatic encephalopathy (HE) is a complication of severe hepatic failure that is characterized by neuropsychiatric manifestations. A case of HE whose laboratory, physiological, and imaging results were similar to that of Creutzfeldt-Jakob disease (CJD) in the process of treatment for HE is presented. CASE REPORT An 84-year-old woman with hepatic encephalopathy (HE) was admitted to our hospital because of acute consciousness disturbance. She had chronic hepatitis type C, liver cirrhosis, and hepatocellular carcinoma, and had had an episode of HE once. Her severe consciousness disturbance did not improve after treatment for concurrent hyperammonemia, unlike in her previous episode. Diffusion-weighted brain magnetic resonance imaging (MRI) showed widespread hyperintensity of the whole cortex. Her electroencephalogram showed periodic sharp wave complexes (PSWCs). Both total t-tau and 14-3-3 proteins were detected in her cerebrospinal fluid. According to these clinical data, CJD was highly suspected. However, the consciousness disturbance was alleviated by the tenth day of admission, and her general condition was markedly improved, which supported the initial diagnosis of HE. CONCLUSIONS The present results suggest that treatable disorders, such as HE, should be considered before making a final diagnosis of a fatal disease such as CJD, since the spectrum of diseases that CJD mimics is vast. We should also aggressively treat patients with severe conditions from which recovery is possible.


Subject(s)
Creutzfeldt-Jakob Syndrome , Hepatic Encephalopathy , Aged, 80 and over , Brain , Creutzfeldt-Jakob Syndrome/diagnosis , Diagnosis, Differential , Electroencephalography , Female , Hepatic Encephalopathy/diagnosis , Hepatic Encephalopathy/etiology , Humans
6.
Clin Neurophysiol Pract ; 6: 29-35, 2021.
Article in English | MEDLINE | ID: mdl-33490740

ABSTRACT

OBJECTIVES: Bickerstaff's brainstem encephalitis (BBE) is a rare post-infectious inflammatory disease, which causes impaired consciousness by the dysfunction of the ascending reticular activating system (ARAS). We aimed to clarify EEG changes possibly caused by the dysfunction of the ARAS in BBE. METHODS: We retrospectively investigated 15 EEGs from 5 patients with definite BBE (i.e., the positivity for serum IgG anti-GQ1b antibodies was mandatory for the diagnosis) admitted to our hospital from January 2014 through December 2019, particularly focusing on whether N1 and N2 sleep patterns were maintained. RESULTS: All of the 10 EEGs recorded when patients had consciousness disturbance were abnormal. Stereotypical EEG changes correlating with their level of consciousness were identified: poorly organized posterior dominant rhythms with maintenance of sleep patterns in patients with mild consciousness disturbance (n = 5); predominant N1 and/or N2 sleep patterns even with external stimuli, including spindle coma pattern, in patients with moderate consciousness disturbance ("unarousable sleep-like" EEG) (n = 4); and generalized slow waves without N1 and N2 sleep patterns in patients with severe consciousness disturbance (n = 1). Among 5 patients, 3 (60%) had "unarousable sleep-like" EEG in their clinical course. CONCLUSIONS: Patients with BBE showed stereotypical EEG changes correlating with their level of consciousness, mostly with maintenance of N1 and N2 sleep patterns, and often exhibited characteristic "unarousable sleep-like" EEG. SIGNIFICANCE: This study revealed characteristic EEG changes possibly caused by the dysfunction of the ARAS, which can be a diagnostic clue for BBE.

7.
Rinsho Shinkeigaku ; 60(11): 758-761, 2020 Nov 27.
Article in Japanese | MEDLINE | ID: mdl-33115990

ABSTRACT

We present the case of an 81-year-old woman who underwent aortic valve replacement and coronary artery bypass surgery by median sternotomy. Following the operation, she experienced distal muscle weakness in her left upper limb and numbness in the medial part of her left forearm and palm. Nerve conduction study revealed low amplitudes of her left ulnar compound muscle action potential (CMAP) and sensory nerve action potential (SNAP), radial CMAP, and medial antebrachial cutaneous SNAP. Needle electromyography showed denervation potentials in the extensor digitorum communis and abductor pollicis brevis. CT and MRI showed a left first rib fracture and a hematoma nearby. Short-T1 inversion recovery image (STIR) showed a high-intensity area in the left root of C8. Based on these findings, we diagnosed the patient with lower trunk brachial plexopathy due to hematoma.


Subject(s)
Brachial Plexus Neuropathies/diagnosis , Brachial Plexus Neuropathies/etiology , Hematoma/etiology , Postoperative Complications/diagnosis , Postoperative Complications/etiology , Sternotomy/adverse effects , Aged, 80 and over , Aortic Valve/surgery , Coronary Artery Bypass , Electromyography , Female , Heart Valve Prosthesis Implantation , Hematoma/diagnosis , Humans , Magnetic Resonance Imaging , Neural Conduction , Tomography, X-Ray Computed
8.
J Stroke Cerebrovasc Dis ; 29(6): 104798, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32249205

ABSTRACT

This is an extremely rare reported case of intravascular large B-cell lymphoma (IVLBCL) presenting with acute hemorrhages and numerous microbleeds. An 80-year-old man presented with consciousness disturbances after convulsion. Computed tomography revealed multiple hemorrhages, and susceptibility-weighted imaging (SWI) demonstrated numerous microbleeds. Brain biopsy showed CD20-positive cells in small vessels; accordingly, IVLBCL was diagnosed. IVLBCL should be considered as a differential diagnosis in multiple cerebral hemorrhages and microbleeds.


Subject(s)
Cerebral Hemorrhage/etiology , Hematoma/etiology , Lymphoma, B-Cell/complications , Vascular Neoplasms/complications , Aged, 80 and over , Antigens, CD20/analysis , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Biomarkers, Tumor/analysis , Biopsy , Cerebral Hemorrhage/diagnostic imaging , Cerebral Hemorrhage/pathology , Cyclophosphamide/administration & dosage , Diffusion Magnetic Resonance Imaging , Doxorubicin/administration & dosage , Hematoma/diagnostic imaging , Hematoma/pathology , Humans , Immunohistochemistry , Lymphoma, B-Cell/diagnostic imaging , Lymphoma, B-Cell/drug therapy , Lymphoma, B-Cell/pathology , Male , Prednisone/administration & dosage , Rituximab/administration & dosage , Tomography, X-Ray Computed , Treatment Outcome , Vascular Neoplasms/diagnostic imaging , Vascular Neoplasms/drug therapy , Vascular Neoplasms/pathology , Vincristine/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...